Effect of glucagon-like peptide-1 receptor agonist in treatment of nonalcoholic fatty liver disease and related mechanism

DOI: 10.3969/j.issn.1001-5256.2021.01.043

• Xiaohan YU^1a , 
• Yulu WANG^1a , 
• Xiaoyang XU^1a , 
• Jian PING^{1a, 1b, 2, 3} , 
• Changqing ZHAO^{1a, 1b, 2, 3 ,  ,} 

• 1a.

  Institute of Hepatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China

• 1b.

  Second Department of Hepatology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China

• 2.

  Shanghai Key Laboratory of Traditional Chinese Clinical Medicine, Shanghai 201203, China

• 3.

  Key Laboratory of Liver and Kidney Diseases, Ministry of Education, Shanghai 201203, China